Myriad Genetics Inc
MYGN· Nasdaq
MYGNMyriad Genetics Inc
Source filing unavailable
| Metric | Q4 2019 | Q4 2018 | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Revenue | $195.10M | $216.80M | $173.20M | $189.30M |
| Net Income | -$8.30M | $2.60M | $15.30M | $18.40M |
| EPS Diluted | -$0.11 | $0.03 | — | — |
Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
